Constanza Neri Morales
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Constanza Neri Morales has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Leal Bernal
Centro de Atención e Investigación Médica CAIMED, Chía, Colombia
2 shared publications - Derly Carolina Hernandez
Centro de Atención e Investigación Médica CAIMED, Chía, Colombia
2 shared publications - Humberto Reynales
Centro de Atención e Investigación Médica CAIMED, Chía, Colombia
2 shared publications - Alba Clemencia Rojas Delgado
Department of Diagnostic Imaging, Fundación Santa Fe de Bogotá, Calle 116 # 9-02, Bogotá 11111, Colombia
1 shared publication - Angel F Maestre
Centro de Atención e Investigación Médica CAIMED, Chía, Colombia
1 shared publication - Carlos Julio Corzo Diaz
Centro de Atención e Investigación Médica CAIMED, Chía, Colombia
1 shared publication
Latest Publications
- Open Access
- 27 February 2026
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 5 (1)
Current landscape of orphan disease clinical research in Colombia: a scoping review
Purpose: The main objective of this scoping review is to evaluate the current state of clinical trial research on orphan diseases in Colombia over the past five years. Methods: A scoping review on the clinical trials studying the orphan diseases listed in the 023 resolution of 2023 in Colombia was conducted. A thorough search strategy was applied to the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) database from the 1st of May 2020 and the 30th of April 2024. Trials were screened and analyzed by two reviewers. Results: A total of 74 clinical trials were included and analyzed for this review. Of the 2247 diseases listed on the Colombian Rare Disease Registry, only 29 are under study in Colombia. The diseases mentioned in the greatest number of clinical trials were Crohn disease (18.9%), idiopathic pulmonary arterial hypertension (13.5%), paroxysmal nocturnal hemoglobinuria (10.8%), multiple sclerosis (9.5%) and idiopathic pulmonary fibrosis (6.8%). Regarding study phase, 70.3% were phase III, 16.2% were phase II, 9.5% were phase II/III and 4.1% were phase I/II. While most studies were conducted in more than one city, Bogota (39.2%), Medellin (33.8%) and Cali (25.7%) had the highest number of clinical trials conducted. Conclusions: The results of this review show a dynamic and diverse field of research on orphan diseases in Colombia; however, they also serve as a reflection on the many barriers faced by both researchers and patients. Further reviews on each individual disease to evaluate their barriers and new treatment options should be conducted.
- 27 February 2026
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 5 (1)
Open AccessCurrent landscape of orphan disease clinical research in Colombia: a scoping review
Purpose: The main objective of this scoping review is to evaluate the current state of clinical trial research on orphan diseases in Colombia over the past five years. Methods: A scoping review on the clinical trials studying the orphan diseases listed in the 023 resolution of 2023 in Colombia was conducted. A thorough search strategy was applied to the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) database from the 1st of May 2020 and the 30th of April 2024. Trials were screened and analyzed by two reviewers. Results: A total of 74 clinical trials were included and analyzed for this review. Of the 2247 diseases listed on the Colombian Rare Disease Registry, only 29 are under study in Colombia. The diseases mentioned in the greatest number of clinical trials were Crohn disease (18.9%), idiopathic pulmonary arterial hypertension (13.5%), paroxysmal nocturnal hemoglobinuria (10.8%), multiple sclerosis (9.5%) and idiopathic pulmonary fibrosis (6.8%). Regarding study phase, 70.3% were phase III, 16.2% were phase II, 9.5% were phase II/III and 4.1% were phase I/II. While most studies were conducted in more than one city, Bogota (39.2%), Medellin (33.8%) and Cali (25.7%) had the highest number of clinical trials conducted. Conclusions: The results of this review show a dynamic and diverse field of research on orphan diseases in Colombia; however, they also serve as a reflection on the many barriers faced by both researchers and patients. Further reviews on each individual disease to evaluate their barriers and new treatment options should be conducted.
- Open Access
- 23 January 2026
- Published by Asociacion Colombiana de Dermatologia y Cirugia Dermatologica in Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
- Vol. 34 (1)
Seguimiento clínico y sociodemográfico de pacientes con psoriasis en una cohorte de población cautiva controlada en el Hospital Militar Central en Colombia
Introducción: la psoriasis es una enfermedad inflamatoria crónica de la piel que afecta la calidad de vida y requiere un manejo integral e individualizado. En Colombia, la Clínica de Psoriasis del Hospital Militar Central (HOMIL) es el centro de remisión nacional para el sistema de salud de las Fuerzas Militares. Existen pocos estudios sobre las características clínicas y sociodemográficas de la psoriasis en este tipo de cohortes. Este estudio tiene como objetivo caracterizar clínica y sociodemográficamente a los pacientes en seguimiento en la Clínica de Psoriasis del HOMIL. Materiales y métodos: estudio observacional descriptivo, corte transversal, de una cohorte retrospectiva de 189 pacientes con psoriasis atendidos en el HOMIL entre 2007 y 2023. Los datos se obtuvieron de la historia clínica. Se utilizaron análisis univariado y bivariado en SPSS 25. Resultados: se incluyeron189 pacientes, mediana de edad 57,7 años, 57,7% hombres; 58,2% casados; 47,7% en estrato 3. Los porcentajes de tratamiento fueron tópico (97,9%), sistémico no biológico (28,6%), biológico (24,9%) y fototerapia (13,7%). El PASI leve pasó del 56% al 91%, mientras que el moderado a severo disminuyó del 44% al 9%. El 90,9% presentó PASI leve y 88,2% tenía DLQI <5. La psoriasis vulgar fue el fenotipo más común (95,8%). El 35,4% tenía comorbilidades cardiovasculares, 34,9% metabólicas y 31,2% artritis psoriásica. Conclusiones: conocer las características de los pacientes con psoriasis es esencial para su manejo. El enfoque multidisciplinario y la capacitación continua hacen de la Clínica de Psoriasis del HOMIL un grupo de atención en salud con las condiciones adecuadas para convertirse en parte de un centro de excelencia.
- 23 January 2026
- Published by Asociacion Colombiana de Dermatologia y Cirugia Dermatologica in Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
- Vol. 34 (1)
Open AccessSeguimiento clínico y sociodemográfico de pacientes con psoriasis en una cohorte de población cautiva controlada en el Hospital Militar Central en Colombia
Introducción: la psoriasis es una enfermedad inflamatoria crónica de la piel que afecta la calidad de vida y requiere un manejo integral e individualizado. En Colombia, la Clínica de Psoriasis del Hospital Militar Central (HOMIL) es el centro de remisión nacional para el sistema de salud de las Fuerzas Militares. Existen pocos estudios sobre las características clínicas y sociodemográficas de la psoriasis en este tipo de cohortes. Este estudio tiene como objetivo caracterizar clínica y sociodemográficamente a los pacientes en seguimiento en la Clínica de Psoriasis del HOMIL. Materiales y métodos: estudio observacional descriptivo, corte transversal, de una cohorte retrospectiva de 189 pacientes con psoriasis atendidos en el HOMIL entre 2007 y 2023. Los datos se obtuvieron de la historia clínica. Se utilizaron análisis univariado y bivariado en SPSS 25. Resultados: se incluyeron189 pacientes, mediana de edad 57,7 años, 57,7% hombres; 58,2% casados; 47,7% en estrato 3. Los porcentajes de tratamiento fueron tópico (97,9%), sistémico no biológico (28,6%), biológico (24,9%) y fototerapia (13,7%). El PASI leve pasó del 56% al 91%, mientras que el moderado a severo disminuyó del 44% al 9%. El 90,9% presentó PASI leve y 88,2% tenía DLQI <5. La psoriasis vulgar fue el fenotipo más común (95,8%). El 35,4% tenía comorbilidades cardiovasculares, 34,9% metabólicas y 31,2% artritis psoriásica. Conclusiones: conocer las características de los pacientes con psoriasis es esencial para su manejo. El enfoque multidisciplinario y la capacitación continua hacen de la Clínica de Psoriasis del HOMIL un grupo de atención en salud con las condiciones adecuadas para convertirse en parte de un centro de excelencia.
- 8 November 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (2) , 469-471
A 7‐Year‐Old Male With a Linear Band‐Like Hair Patch
- 8 November 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (2) , 469-471
A 7‐Year‐Old Male With a Linear Band‐Like Hair Patch
- Open Access
- 3 April 2025
- Published by Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
- Vol. 12 (2)
Use of the FINDRISC scale in the department of Cundinamarca, Colombia: A descriptive and cross-sectional study
Background: Type II diabetes (T2D) is a chronic disease with high rates of morbidity and mortality, which implies a great impact on the economy and health systems due to its high prevalence rates, complications, and costs. Prediabetes arises as an abnormal state that precedes type II diabetes and is associated with multiple risk factors. Therefore, strategies such as the FINDRISC survey have emerged to identify people at risk of developing prediabetes and type II diabetes as early as possible. Objective: The objective of this study is to identify individuals with a high risk of developing type II diabetes and prediabetes using the FINDRISC scale in a cohort of adults in Cundinamarca, Colombia. Methodology: Descriptive observational cross-sectional study developed in 3257 people over 18 years of age without a previous diagnosis of type II diabetes. Results are presented in absolute frequency measures and percentages. FINDRISC variables included age, body mass index (BMI), waist circumference (WC), diet, physical activity, history of hypertension, history of hyperglycemia, and family history of type II diabetes. Results: Of the total respondents, 48% had at least a moderate risk of developing type II diabetes within the following 10 years (FINDRISC >=12). It was observed that a large number of subjects were not meeting goals for modifiable risk factors evaluated by the scale, such as physical activity (69%), diet (60%), and body mass index (70%). The family history of diabetes mellitus was a positive factor in more than half of the respondents. Conclusion: The FINDRISC scale may allow us to reduce the high rates of morbidity and mortality, associated complications, and high rates of people undiagnosed with these conditions. The results emphasize the importance of habits and lifestyle in the population at risk for diabetes and prediabetes.
- 3 April 2025
- Published by Asociacion Colombiana de Endocrinologia, Diabetes y Metabolismo in Revista Colombiana de Endocrinología, Diabetes & Metabolismo
- Vol. 12 (2)
Open AccessUse of the FINDRISC scale in the department of Cundinamarca, Colombia: A descriptive and cross-sectional study
Background: Type II diabetes (T2D) is a chronic disease with high rates of morbidity and mortality, which implies a great impact on the economy and health systems due to its high prevalence rates, complications, and costs. Prediabetes arises as an abnormal state that precedes type II diabetes and is associated with multiple risk factors. Therefore, strategies such as the FINDRISC survey have emerged to identify people at risk of developing prediabetes and type II diabetes as early as possible. Objective: The objective of this study is to identify individuals with a high risk of developing type II diabetes and prediabetes using the FINDRISC scale in a cohort of adults in Cundinamarca, Colombia. Methodology: Descriptive observational cross-sectional study developed in 3257 people over 18 years of age without a previous diagnosis of type II diabetes. Results are presented in absolute frequency measures and percentages. FINDRISC variables included age, body mass index (BMI), waist circumference (WC), diet, physical activity, history of hypertension, history of hyperglycemia, and family history of type II diabetes. Results: Of the total respondents, 48% had at least a moderate risk of developing type II diabetes within the following 10 years (FINDRISC >=12). It was observed that a large number of subjects were not meeting goals for modifiable risk factors evaluated by the scale, such as physical activity (69%), diet (60%), and body mass index (70%). The family history of diabetes mellitus was a positive factor in more than half of the respondents. Conclusion: The FINDRISC scale may allow us to reduce the high rates of morbidity and mortality, associated complications, and high rates of people undiagnosed with these conditions. The results emphasize the importance of habits and lifestyle in the population at risk for diabetes and prediabetes.
- 1 June 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (5) , e230041
Interventional Radiology Is a Growing Area that Is Underrepresented in Some Regions
- 1 June 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (5) , e230041
Interventional Radiology Is a Growing Area that Is Underrepresented in Some Regions